Evidence map›Paper›PMID 24454986›Full record

ReviewOxidative medicine and cellular longevity2013

Modulation of antioxidant enzymatic activities by certain antiepileptic drugs (valproic acid, oxcarbazepine, and topiramate): evidence in humans and experimental models.

Noemí Cárdenas-Rodríguez, Elvia Coballase-Urrutia, Liliana Rivera-Espinosa, Arantxa Romero-Toledo, Aristides Sampieri, Daniel Ortega-Cuellar, Hortencia Montesinos-Correa, Esaú Floriano-Sánchez, Liliana Carmona-Aparicio

Open access · hybridAbstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Idiopathic extracranial internal carotid artery vasospasm: case report and systematic review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Pooled it
  2. Review
  3. The Oxidative Stress in Epilepsy-Focus on Melatonin.International journal of molecular sciences · 2024
    Review
  4. Article
  5. Mechanisms of neurodevelopmental toxicity of topiramate.Critical reviews in toxicology · 2024
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Second Generation of Antiepileptic Drugs and Oxidative Stress.International journal of molecular sciences · 2023
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Noemí Cárdenas-RodríguezLaboratory of Neurochemistry, National Institute of Pediatrics, 04530 DF, Mexico.
Elvia Coballase-UrrutiaLaboratory of Neurochemistry, National Institute of Pediatrics, 04530 DF, Mexico.
Liliana Rivera-EspinosaLaboratory of Pharmacology, National Institute of Pediatrics, 04530 DF, Mexico.
Arantxa Romero-ToledoLaboratory of Neurochemistry, National Institute of Pediatrics, 04530 DF, Mexico.
Aristides SampieriLaboratory of Molecular Biology and Genomics, Faculty of Sciences, University City, UNAM, 04150 DF, Mexico.
Daniel Ortega-CuellarLaboratory of Experimental Nutrition, National Institute of Pediatrics, 04530 DF, Mexico.
Hortencia Montesinos-CorreaService of Endocrinology, National Institute of Pediatrics, 04530 DF, Mexico.
Esaú Floriano-SánchezSection of Research and Graduate Studies, IPN, 11430 DF, Mexico.
Liliana Carmona-AparicioLaboratory of Neurochemistry, National Institute of Pediatrics, 04530 DF, Mexico.
Instituto Politécnico Nacional · MXNational Hospital of Pediatrics · VN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is estimated that at least 100 million people worldwide will suffer from epilepsy at some point in their lives. This neurological disorder induces brain death due to the excessive liberation of glutamate, which activates the postsynaptic N-methyl-D-aspartic acid (NMDA) receptors, which in turn cause the reuptake of intracellular calcium (excitotoxicity). This excitotoxicity elicits a series of events leading to nitric oxide synthase (NOS) activation and the generation of reactive oxygen species (ROS). Several studies in experimental models and in humans have demonstrated that certain antiepileptic drugs (AEDs) exhibit antioxidant effects by modulating the activity of various enzymes associated with this type of stress. Considering the above-mentioned data, we aimed to compile evidence elucidating how AEDs such as valproic acid (VPA), oxcarbazepine (OXC), and topiramate (TPM) modulate oxidative stress.

Indexed as

Disease Models, AnimalAnimalsAnticonvulsantsAntioxidantsCarbamazepineEnzymesFructoseHumansOxcarbazepineOxidative StressTopiramateValproic AcidAnticonvulsantsAntioxidantsCarbamazepineEnzymesFructoseOxcarbazepineTopiramateValproic Acid

Identifiers

PMID24454986
PMCPMC3877618
OpenAlexW2031984049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.